Home
For those of you who weren't able to join us in person at the XVI International AIDS Conference in Toronto, we've brought the conference to you online! Kaisernetwork.org provided full online coverage of the conference and AVAC has posted here on the Clearinhouse the webcasts and slides from some of the best sessions. You can even see members of the AVAC staff in action in various conference sessions and satellites.
Look below for descriptions, webcasts and slides from some of the events featured on the “Vaccines, Microbicides and New Prevention Technologies Toronto ‘Roadmap’”
For the complete conference archive, visit http://www.kaisernetwork.org/aids2006/
AVAC Posters and Presentations (click title to download pdf)
Presentations:
- Introducing HPV Vaccines...A model for HIV vaccines for young people?!
Posters:
- Clinical Trials Process
- Towards a New GCP: Good Community Practice in Prevention Research
- Intellectual Property Issues for AIDS Vaccines at the Crossroads
- Optimizing Research Intellectual Property for Vaccines
- Adding It All Up: Funding for HIV vaccine and microbicide research and development between 2000 and 2005
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Additional presentations from the conference featured on the Roadmap (click titles below to jump to selection)
- Satellite: "Almost Everything You Ever Wanted to Know About Vaccinology: A Short Course on How Vaccines Work"
- Satellite: “The Potential Role of HPV Vaccines in Improving HIV Prevention among Young Girls and Women”
- Plenary Session: “Prevention: Proven Approaches and New Technologies”
- Oral Abstract Session: “Male Circumcision: Is it Time To Act?”
- Symposium: “A world without AIDS: The long road to effective HIV vaccines”
- Oral Abstract Session: “Microbicide Development”
- Press Conference: Highlights from Late Breaker Abstracts -- includes comments on late-breaker results from Ghana PrEP trial
===============================================================================================================
Satellite: Almost Everything You Ever Wanted to Know About Vaccinology: A Short Course on How Vaccines Work
**Download slides from the presentation**
English
Français
Español
中国
"Introduction and Framing"
Mitchell Warren
Executive Director
AIDS Vaccine Advocacy Coalition (AVAC)
"The Road to an AIDS Vaccine"
Huntly Collins
Assistant Professor of Journalism
La Salle University
"Vaccines 101"
Stanley Plotkin, MD
Emeritus Professor of Pediatrics
University of Pennsylvania
Senior Adviser
sanofi pasteur
"Vaccine Development Issues"
Huntly Collins
back to top
==============================================================================================================
Satellite: “The Potential Role of HPV Vaccines in Improving HIV Prevention among Young Girls and Women”
Speakers for this session:
"Preparing for HPV Vaccines: Policy and Programmatic Issues"
Nathalie Broutet, M.D., Ph.D.
Reproductive Health and Research Department
World Health Organization
"The Potential of HPV Vaccines in Strengthening HIV Prevention"
Arletty Pinel, M.D.
Chief
UNFPA Reproductive Health Branch
"HPV Vaccines as a Model for HIV Vaccines for Young People"
Emily Bass
AIDS Vaccine Advocacy Coalition
"HPV Vaccines: Addressing the Gaps in Understudied Groups"
Kevin Moody, Eh.D.
International Coordinator and CEO
The Global Network of People living with HIV/AIDS
"Diagnostic Platform for HPV, Cervical Cancer and STI's"
Vinand Nantulya, M.D., Ph.D.
Senior Policy and Implementation Officer
Foundation for Innovative New Diagnostics
back to top
==============================================================================================================
Plenary Session: “Prevention: Proven Approaches and New Technologies”
Speakers for this session:
"Conceptual Frameworks and HIV/AIDS Prevention Paradigms"
Cristina Pimenta, Ph.D.
Executive Director
Brazilian Interdisciplinary AIDS Association
"Microbicides and Other Prevention Technologies"
Gita Ramjee, Ph.D.
Director, HIV/AIDS Lead Programme
South African Medical Research Council
"Dynamics of HIV/AIDS Vaccine Research: From Dream and Nightmare to Reality and Hope"
Francoise Barre-Sinoussi, Ph.D.
Director, Regulation of Retroviral Infections Unit
Institut Pasteur
“Global Harm Reduction Efforts to Control HIV Among Injecting Drug Users: Current status"
Alex Wodak, M.D.
Director, Drug and Alcohol Service
St. Vincent's Hospital
back to top
==============================================================================================================
Oral Abstract Session: “Male Circumcision: Is it Time To Act?”
Speakers for this session:
"Cost-Effectiveness of Male Circumcision in Sub-Saharan Africa"
Robert Bailey
United States
Professor, Epidemiology & Biostatistics
University of Illinois, Chicago, School of Public Health
"A Randomized Controlled Trial of Male Circumcision to Reduce HIV Incidence in Kisumu, Kenya: Progress to Date"
Douglas N. Shaffer, M.D.
Kenya
Emergency Plan Program Director
"Male Circumcision and HIV Infection Risk Among Tea Plantation Residents in Kericho, Kenya: Incidence Results After 1.5 Years of Follow-Up"
Kyeen Mesesan
United States
M.D./Ph.D. Candidate
Yale University School of Medicine
"The Potential Benefits of Expanded Male Circumcision Programs in Africa: Predicting the Population-Level Impact on Heterosexual HIV Transmission in Soweto"
James Kahn, M.D.
United States
Professor, Division of Clinical Epidemiology, Institute for Health Policy Studies
University of California-San Francisco
“Male Circumcision in Siaya and Bondo Districts, Kenya: a Prospective Cohort Study to Assess Behavioural Disinhibition Following Circumcision"
Kawango Agot
Kenya
Project Coordinator, Lumumba Health Center
University of Nairobi
back to top
==============================================================================================================
Symposium: “A world without AIDS: The long road to effective HIV vaccines”
Speakers for this session:
Co-Chairs
Peggy Johnston
United States
Assistant Director, HIV/AIDS Vaccines
National Institute of Allergy and Infectious Diseases
Mitchell Warren
United States
Executive Director
AIDS Vaccine Advocacy Coalition
"Scientific Challenges for the Development of HIV Vaccines"
Rafick-Pierre Sekaly
Canada
Adjunct Professor, Immunology
McGill University
"Challenges to Industry in Developing HIV Vaccines"
Jim Tartaglia
France
Vice President, Research and Development
Sanofi Pasteur
"Engaging the Community in HIV Vaccine Issues"
Elise Levendal
South Africa
Interim Director
South African AIDS Vaccine Initiative
“The Global HIV Vaccine Enterprise"
Jose Esparza, M.D., Ph.D.
United States
Bill and Melinda Gates Foundation
back to top
==============================================================================================================
Oral Abstract Session: “Microbicide Development”
Speakers for this session:
Co-Chairs
Robin Shattock
Zeda Rosenberg, Sc.D.
chief executive
International Partnership for Microbicides
"Invited Presentation: Overview of Microbicide Development"
Robin Shattock, M.D.
United Kingdom
Reader
Department of Cellular and Molecular Medicine: Infectious Diseases
St George's Hospital Medical School
"Contraceptive and Non-Contraceptive Thiourea Non-Nucleoside Inhibitor-Based Anti-HIV Microbicides"
Download the presentation slides
Osmond D'Cruz
Director
Department of Reproductive Biology
Parker Hughes Institute
"Characterization of In Vitro Release and In Vivo Delivery of TMC120 with an Intravaginal Ring: Implications for Microbicide Delivery"
Download the presentation slides
Joseph Romano
Executive Director, Research and Development
International Partnership for Microbicides
"Trappin-2: Discovery of a Novel Inhibitor of HIV Highly Elevated in HIV-Resistant Sex Workers"
Download the presentation slides
Shehzad Iqbal
Medical Microbiology
University of Manitoba
"Preclinical Assessment of Topical Microbicides: Development of a Microbicide Quality Assurance Program (MQAP)"
James Cummins, Ph.D.
back to top
==============================================================================================================
Press Conference: Highlights from Late Breaker Abstracts -- Includes comments on late-breaker results from Ghana PrEP trial
**Transcript**
Speakers for this session:
Highlights from Late Breaker Abstracts Tracks B, C and D
Sharon Riddler
Assistant Professor, Division of Infectious Diseases
University of Pittsburg
Paula Munderi
Clinical Research Fellow, Imperial College of London
Medical Research Council Programme on AIDS in Uganda
Leigh Peterson
Family Health International
Lynne Leonard, Ph.D.
Assistant Professor, Department of Epidemiology and Community Medicine
University of Ottawa Faculty of Medicine
Leigh Anne Shafer
Alex Kamali
back to top
=====================================================================================
If you haven't already, we encourage you to sign up for the Advocates' Network for continuous updates on conferences, events or activities related to AIDS vaccine research around the world and up-to-date information on all things AIDS vaccines.
If you would like to sign up for the Advocates’ Network mailing list go here.
|
